Review
doi: 10.1016/s0024-3205(01)01053-0.
Anticholinergic therapy for airway diseases
Affiliations
- PMID: 11392627
- DOI: 10.1016/s0024-3205(01)01053-0
Item in Clipboard
Review
Anticholinergic therapy for airway diseases
Life Sci.
.
Abstract
Anticholinergics are commonly used in the treatment of airway diseases. While their effectiveness in chronic asthma offers no advantage over beta-agonists, evidence continues to accumulate suggesting substantial additional benefit in acute asthma attacks. This increased response to anticholinergics suggest that cholinergic bronchoconstriction is increased in acute asthma. Multiple mechanisms related to changes in expression and function of inhibitory M2 muscarinic receptors on the airway parasympathetic nerves may be involved, and are discussed. The use of anticholinergics in chronic obstructive pulmonary disease and in rhinitis are also considered.
Similar articles
-
Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.Trends Pharmacol Sci. 2015 Mar;36(3):164-71. doi: 10.1016/j.tips.2014.11.005. Epub 2014 Dec 13. Trends Pharmacol Sci. 2015. PMID: 25511176 Review.
-
Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.Proc Am Thorac Soc. 2005;2(4):297-304; discussion 311-2. doi: 10.1513/pats.200504-043SR. Proc Am Thorac Soc. 2005. PMID: 16267352 Review.
-
Muscarinic receptors in human airways.J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1065-8. doi: 10.1016/s0091-6749(95)70209-1. J Allergy Clin Immunol. 1995. PMID: 7751523 Review.
-
Muscarinic receptor subtypes: implications for therapy.Agents Actions Suppl. 1993;43:243-52. doi: 10.1007/978-3-0348-7324-6_21. Agents Actions Suppl. 1993. PMID: 8368167 Review.
-
Muscarinic acetylcholine receptors and airway diseases.Pharmacol Ther. 2003 Apr;98(1):59-69. doi: 10.1016/s0163-7258(03)00004-4. Pharmacol Ther. 2003. PMID: 12667888 Review.
Cited by
-
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease.Ther Clin Risk Manag. 2014 Jun 13;10:449-53. doi: 10.2147/TCRM.S39710. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24966682 Free PMC article. Review.
-
Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors.Drug Des Devel Ther. 2012;6:317-22. doi: 10.2147/DDDT.S36555. Epub 2012 Nov 1. Drug Des Devel Ther. 2012. PMID: 23139625 Free PMC article. Review.
-
Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways.Respir Res. 2005 May 31;6(1):48. doi: 10.1186/1465-9921-6-48. Respir Res. 2005. PMID: 15927078 Free PMC article.
-
Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling.Trends Pharmacol Sci. 2008 Aug;29(8):413-20. doi: 10.1016/j.tips.2008.05.006. Epub 2008 Jul 6. Trends Pharmacol Sci. 2008. PMID: 18606460 Free PMC article. Review.
-
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?Front Pharmacol. 2022 Jan 20;12:784335. doi: 10.3389/fphar.2021.784335. eCollection 2021. Front Pharmacol. 2022. PMID: 35126123 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
